Similarly, in the TARGET database, gene expression level of FRMD4B, but not MITF and TGFBR3, in BCP‐ALL patients with relapse (n = 167) was significantly lower than those without relapse (n = 29; Figure 3B). This evidence concerns the gene FRMD4B and acute lymphoblastic leukemia.